Insightec

Insightec is a commercial-stage medical device company that has developed and markets the Exablate Neuro platform, an MR-guided focused ultrasound system for the non-invasive treatment of neurological movement disorders. The company's technology represents a significant innovation in neurosurgery, offering a precise, incisionless procedure with immediate therapeutic effect and minimal complications, allowing patients to typically return home the same day. Founded in 1999 and headquartered in Miami, Florida, Insightec is a private company that has established a commercial footprint for its FDA-approved system in treatment centers worldwide. Its core value proposition is transforming patient care by providing a non-invasive alternative to traditional brain surgery for tremor conditions.

Magnetic Resonance-guided Focused Ultrasound (MRgFUS) platform (Exablate) that non-invasively delivers precise acoustic energy to ablate or modulate tissue, integrated with real-time MRI for planning, temperature monitoring, and outcome assessment.

Insightec competes with invasive procedures like deep brain stimulation (DBS) systems from Medtronic, Boston Scientific, and Abbott, and non-invasive radiosurgery like Gamma Knife (Elekta). In its pipeline areas, it faces competition from a wide range of pharmaceutical, device, and radiotherapy companies. Its main differentiator is its unique, approved MRgFUS platform for non-invasive brain ablation.